Brief: Redhill Provides Research And Development Update

Redhill Biopharma

22/05/2023 12:52

May 22 (Reuters) - Redhill Biopharma Ltd  2RH0y.F :
    * REDHILL PROVIDES RESEARCH AND DEVELOPMENT UPDATE
    * REDHILL BIOPHARMA LTD - HAS ELECTED TO TERMINATE RHB-204'S
U.S.
PHASE 3 STUDY FOR NON-TUBERCULOSIS MYCOBACTERIA (NTM) DISEASE
DUE TO LOW ACCRUAL RATE
    * REDHILL BIOPHARMA LTD - PLANS TO SHIFT RESOURCES TO MORE
RAPIDLY
ADVANCE RHB-107 LATE-STAGE DEVELOPMENT FOR OUTPATIENT TREATMENT
OF COVID-19

Source text for Eikon:  ID:nPn23PHWTa 
Further company coverage:  2RH0y.F 

 ((reuters.briefs@thomsonreuters.com;))